Tags

Type your tag names separated by a space and hit enter

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report.
Psychosom Med 2006 Sep-Oct; 68(5):645-50PM

Abstract

OBJECTIVE

The National Heart, Lung, and Blood Institute convened an interdisciplinary working group of experts to develop recommendations for the assessment and treatment of depression in patients with coronary heart disease (CHD).

METHOD

Consensus of experts.

RESULTS

Our current recommendations are that the Beck Depression Inventory-I be employed for epidemiological studies of depression and CHD, that the Patient Health Questionnaire 2-item version be employed for screening for trial eligibility, that the Depression Interview and Structured Hamilton (DISH) be employed for diagnostic ascertainment for trial inclusion, and that the Hamilton rating scale, which is part of the DISH, be employed for both depression symptom reduction and the remission criterion in any trial. We further recommend that a randomized controlled trial be undertaken to determine whether selective serotonin reuptake inhibitors, psychotherapy, or combined treatment can reduce the risk of CHD events and mortality associated with depression in CHD patients.

CONCLUSIONS

This report summarizes the recommendations made by the working group and discusses the rationale for each recommendation, the strengths and weaknesses of alternative approaches to assessment and treatment, and the implications for future research in this area.

Authors+Show Affiliations

Department of Medicine, Columbia University College of Physicians and Surgeons, 622 W 168th St, PH9 Center, Room 941, New York, NY 10032, USA. kd2124@columbia.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Consensus Development Conference, NIH
Journal Article
Practice Guideline

Language

eng

PubMed ID

17012516

Citation

Davidson, Karina W., et al. "Assessment and Treatment of Depression in Patients With Cardiovascular Disease: National Heart, Lung, and Blood Institute Working Group Report." Psychosomatic Medicine, vol. 68, no. 5, 2006, pp. 645-50.
Davidson KW, Kupfer DJ, Bigger JT, et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med. 2006;68(5):645-50.
Davidson, K. W., Kupfer, D. J., Bigger, J. T., Califf, R. M., Carney, R. M., Coyne, J. C., ... Suls, J. M. (2006). Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosomatic Medicine, 68(5), pp. 645-50.
Davidson KW, et al. Assessment and Treatment of Depression in Patients With Cardiovascular Disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med. 2006;68(5):645-50. PubMed PMID: 17012516.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. AU - Davidson,Karina W, AU - Kupfer,David J, AU - Bigger,J Thomas, AU - Califf,Robert M, AU - Carney,Robert M, AU - Coyne,James C, AU - Czajkowski,Susan M, AU - Frank,Ellen, AU - Frasure-Smith,Nancy, AU - Freedland,Kenneth E, AU - Froelicher,Erika S, AU - Glassman,Alexander H, AU - Katon,Wayne J, AU - Kaufmann,Peter G, AU - Kessler,Ronald C, AU - Kraemer,Helena C, AU - Krishnan,K Ranga R, AU - Lespérance,François, AU - Rieckmann,Nina, AU - Sheps,David S, AU - Suls,Jerry M, AU - ,, PY - 2006/10/3/pubmed PY - 2006/11/10/medline PY - 2006/10/3/entrez SP - 645 EP - 50 JF - Psychosomatic medicine JO - Psychosom Med VL - 68 IS - 5 N2 - OBJECTIVE: The National Heart, Lung, and Blood Institute convened an interdisciplinary working group of experts to develop recommendations for the assessment and treatment of depression in patients with coronary heart disease (CHD). METHOD: Consensus of experts. RESULTS: Our current recommendations are that the Beck Depression Inventory-I be employed for epidemiological studies of depression and CHD, that the Patient Health Questionnaire 2-item version be employed for screening for trial eligibility, that the Depression Interview and Structured Hamilton (DISH) be employed for diagnostic ascertainment for trial inclusion, and that the Hamilton rating scale, which is part of the DISH, be employed for both depression symptom reduction and the remission criterion in any trial. We further recommend that a randomized controlled trial be undertaken to determine whether selective serotonin reuptake inhibitors, psychotherapy, or combined treatment can reduce the risk of CHD events and mortality associated with depression in CHD patients. CONCLUSIONS: This report summarizes the recommendations made by the working group and discusses the rationale for each recommendation, the strengths and weaknesses of alternative approaches to assessment and treatment, and the implications for future research in this area. SN - 1534-7796 UR - https://www.unboundmedicine.com/medline/citation/17012516/Assessment_and_treatment_of_depression_in_patients_with_cardiovascular_disease:_National_Heart_Lung_and_Blood_Institute_Working_Group_Report_ L2 - http://Insights.ovid.com/pubmed?pmid=17012516 DB - PRIME DP - Unbound Medicine ER -